DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 040133
The generic ingredient in HYDROXYCHLOROQUINE SULFATE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
Summary for 040133
Tradename: | HYDROXYCHLOROQUINE SULFATE |
Applicant: | Watson Labs |
Ingredient: | hydroxychloroquine sulfate |
Patents: | 0 |
Therapeutic Class: | Antiparasitics |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 040133
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 040133 | ANDA | Actavis Pharma, Inc. | 0591-3041 | N | 0591-3041-05 |
HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 040133 | ANDA | Actavis Pharma, Inc. | 0591-3041 | N | 0591-3041-01 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Nov 30, 1995 | TE: | AB | RLD: | No |
Complete Access Available with Subscription